Annual CFO
$9.62B$1.84B+23.66%
Summary
- Current Value
- As of today, GSK annual cash from operations is $9.62B, up +23.66% on
- Historical Performance
- GSK annual cash from operations is up +17.94% over the past 3 years, and down -1.85% over the past 5 years
- All-Time High Comparison
- GSK annual cash from operations is currently -23.18% below its historical high of $12.53B set on
- 3-Year Low Comparison
- GSK annual cash from operations is +23.66% above its 3-year low of $7.78B reached on
- Sector Comparison
- GSK annual cash from operations is higher than 99.32% of companies in Healthcare sector
Cash From Operations Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Operations | $9.62B | +23.7% | +17.9% | -1.9% | +1.4% | |
| Quarterly Cash From Operations | $2.74B | -3.2% | +56.8% | -40.7% | +50.7% | |
| TTM Cash From Operations | $9.66B | +22.9% | +19.4% | -1.4% | +1.8% | |
| Price | $58.48 | +60.4% | +63.2% | +61.4% | +50.4% | |
| Annual Cash From Investing | -$7.71B | -334.4% | +29.1% | -387.2% | -150.7% | |
| Annual Cash From Financing | -$2.15B | +59.0% | -204.8% | +81.9% | +71.0% | |
| Annual Free Cash Flow | $5.69B | +43.2% | +5.8% | -17.9% | -18.3% | |
| Annual CAPEX | $3.93B | +3.2% | +41.4% | +37.0% | +55.9% | |
| Annual Net Income | $8.29B | +119.8% | +36.7% | +1.2% | +189.8% |
Cash From Operations Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $9.62B | at high | |
| 5Y | $9.91B | -2.8% | |
| All | $12.53B | -23.2% |
Cash From Operations Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $7.78B | +23.7% | |
| 5Y | $7.78B | +23.7% | |
| All | $1.75B | +449.3% |
Cash From Operations History
FAQ
What is the current annual cash from operations of GSK?
As of today, GSK annual cash from operations is $9.62B
What is 1-year change in GSK annual cash from operations?
GSK annual cash from operations is up +23.66% year-over-year
What is 3-year change in GSK annual cash from operations?
GSK annual cash from operations is up +17.94% over the past 3 years
How far is GSK annual cash from operations from its all-time high?
GSK annual cash from operations is currently -23.18% below its historical high of $12.53B set on December 31, 2008
How does GSK annual cash from operations rank versus sector peers?
GSK annual cash from operations is higher than 99.32% of companies in Healthcare sector
When is GSK next annual earnings release?
As of today, the next annual earnings release for GSK has not been scheduled
Quarterly CFO
$2.74B$287.53M-9.49%
Summary
- Current Value
- As of today, GSK quarterly cash from operations is $2.74B, down -9.49% on
- Historical Performance
- GSK quarterly cash from operations is down -3.20% year-over-year, and up +56.80% over the past 3 years
- All-Time High Comparison
- GSK quarterly cash from operations is currently -46.39% below its historical high of $5.12B set on
- 3-Year Low Comparison
- GSK quarterly cash from operations is +2277.03% above its 3-year low of $115.43M reached on
- Sector Comparison
- GSK quarterly cash from operations is higher than 99.72% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Operations | $2.74B | -9.5% | -3.2% | +56.8% | -40.7% | |
| Annual Cash From Operations | $9.62B | – | +23.7% | +17.9% | -1.9% | |
| TTM Cash From Operations | $9.66B | -0.9% | +22.9% | +19.4% | -1.4% | |
| Price | $58.48 | +23.5% | +60.4% | +63.2% | +61.4% | |
| Quarterly Cash From Investing | -$3.18B | -47.9% | -110.9% | -726.8% | -7400.6% | |
| Quarterly Cash From Financing | $1.09B | +163.8% | +228.9% | +183.1% | +143.1% | |
| Quarterly Free Cash Flow | $1.40B | -23.6% | +5.0% | +57.4% | -60.2% | |
| Quarterly CAPEX | $1.35B | +11.9% | -10.4% | +56.2% | +20.6% | |
| Quarterly Net Income | $966.83M | -66.6% | +50.6% | -49.3% | -12.7% |
Quarterly Cash From Operations Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.03B | -9.5% | |
| 3Y | $3.62B | -24.2% | |
| 5Y | $4.70B | -41.6% | |
| All | $5.12B | -46.4% |
Quarterly Cash From Operations Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.42B | +93.0% | |
| 3Y | $115.43M | +2277.0% | |
| 5Y | $115.43M | +2277.0% | |
| All | -$2.73B | +200.5% |
Quarterly Cash From Operations History
FAQ
What is the current quarterly cash from operations of GSK?
As of today, GSK quarterly cash from operations is $2.74B
What is GSK quarterly cash from operations most recent change?
GSK quarterly cash from operations was down -9.49% on December 31, 2025
What is 1-year change in GSK quarterly cash from operations?
GSK quarterly cash from operations is down -3.20% year-over-year
How far is GSK quarterly cash from operations from its all-time high?
GSK quarterly cash from operations is currently -46.39% below its historical high of $5.12B set on December 31, 2018
How does GSK quarterly cash from operations rank versus sector peers?
GSK quarterly cash from operations is higher than 99.72% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
TTM CFO
$9.66B$90.77M-0.93%
Summary
- Current Value
- As of today, GSK TTM cash from operations is $9.66B, down -0.93% on
- Historical Performance
- GSK TTM cash from operations is up +22.92% year-over-year, and up +19.41% over the past 3 years
- All-Time High Comparison
- GSK TTM cash from operations is currently -26.26% below its historical high of $13.10B set on
- 3-Year Low Comparison
- GSK TTM cash from operations is +107.72% above its 3-year low of $4.65B reached on
- Sector Comparison
- GSK TTM cash from operations is higher than 99.26% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Operations | $9.66B | -0.9% | +22.9% | +19.4% | -1.4% | |
| Annual Cash From Operations | $9.62B | – | +23.7% | +17.9% | -1.9% | |
| Quarterly Cash From Operations | $2.74B | -9.5% | -3.2% | +56.8% | -40.7% | |
| Price | $58.48 | +23.5% | +60.4% | +63.2% | +61.4% | |
| TTM Cash From Investing | -$7.74B | -27.6% | -331.9% | +28.3% | -388.5% | |
| TTM Cash From Financing | -$2.15B | +47.3% | +59.3% | -206.4% | +81.9% | |
| TTM Free Cash Flow | $5.71B | +1.2% | +42.4% | +7.1% | -17.6% | |
| TTM CAPEX | $3.95B | -3.8% | +2.6% | +43.2% | +37.6% | |
| TTM Net Income | $8.29B | +4.1% | +121.4% | +35.1% | +1.9% |
TTM Cash From Operations Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $9.75B | -0.9% | |
| 3Y | $9.75B | -0.9% | |
| 5Y | $13.10B | -26.3% | |
| All | $13.10B | -26.3% |
TTM Cash From Operations Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $7.86B | N/A | +22.9% |
| 3Y | $4.65B | +107.7% | |
| 5Y | $4.65B | +107.7% | |
| All | $1.75B | +452.3% |
TTM Cash From Operations History
FAQ
What is the current TTM cash from operations of GSK?
As of today, GSK TTM cash from operations is $9.66B
What is GSK TTM cash from operations most recent change?
GSK TTM cash from operations was down -0.93% on December 31, 2025
What is 1-year change in GSK TTM cash from operations?
GSK TTM cash from operations is up +22.92% year-over-year
How far is GSK TTM cash from operations from its all-time high?
GSK TTM cash from operations is currently -26.26% below its historical high of $13.10B set on June 30, 2022
How does GSK TTM cash from operations rank versus sector peers?
GSK TTM cash from operations is higher than 99.26% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
Data Sources & References
- GSK Official Website www.gsk.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1131399/000165495426000892/0001654954-26-000892-index.htm
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk